Stock Based Compensation (Tables)

12 Months Ended

Jun. 30, 2013

Stock Based Compensation

Schedule of amounts of stock-based compensation expense recognized

	Years Ended
	June 30, 2013		July 1, 2012		July 3, 2011
	(in thousands, except per share data)
Stock options	$	477	$	1,073	$	1,181
Restricted stock awards	3,806		3,777		2,780
Total	4,283		4,850		3,961
Deferred income tax benefit	1,555		1,796		1,381
Stock-based compensation expense, net	$	2,728	$	3,054	$	2,580

Schedule of stock-based compensation expense recorded within operating expenses

	Years Ended
	June 30, 2013		July 1, 2012		July 3, 2011
	(in thousands)
Marketing and sales	$	1,499	$	1,755	$	1,587
Technology and development	428		600		791
General and administrative	2,356		2,495		1,583
Total	$	4,283	$	4,850	$	3,961

Schedule of assumptions used to estimate the fair value of the stock options

	Years ended
	June 30, 2013			July 1, 2012			July 3, 2011
Weighted average fair value of options granted	$	2.95		$	1.84		$	1.23
Expected volatility	72		%	72		%	68		%
Expected life (in years)	6.4			8.0			7.5
Risk-free interest rate	0.7		%	0.9		%	1.3		%
Expected dividend yield	0.0		%	0.0		%	0.0		%

Summary of stock option activity

The following table summarizes stock option activity during the year ended June 30, 2013:

	Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value (000s)
Outstanding beginning of period	6,711,280		$	4.48
Granted	35,000		$	4.55
Exercised	(191,947	)	$	2.36
Forfeited/Expired	(1,831,093	)	$	6.23
Outstanding end of period	4,723,240		$	3.89	5.1 years	$	12,536
Options vested or expected to vest at end of period	4,572,098		$	3.94	4.9 years	$	11,950
Exercisable at June 30, 2013	2,917,540		$	4.88	3.4 years	$	5,508

Summary of information about stock options outstanding and exercisable, by exercise price range

The following table summarizes information about stock options outstanding at June 30, 2013:

	Options Outstanding				Options Exercisable
Exercise Price	Options Outstanding	Weighted- Average Remaining Contractual Life	Weighted- Average Exercise Price		Options Exercisable	Weighted- Average Exercise Price
$1.69 – 1.79	1,080,500	7.3 years	$	1.79	257,000	$	1.79
$2.01 – 2.63	1,078,400	8.2 years	$	2.62	177,300	$	2.62
$2.77 – 3.11	1,193,753	3.1 years	$	3.09	1,156,153	$	3.09
$3.26 – 6.52	645,234	3.1 years	$	6.09	601,734	$	6.09
$6.90 – 11.81	725,353	2.1 years	$	8.28	725,353	$	8.28
	4,723,240	5.1 years	$	3.89	2,917,540	$	4.88

Summary of activity of non-vested restricted stock awards

The following table summarizes the activity of non-vested restricted stock during the year ended June 30, 2013:

	Shares		Weighted Average Grant Date Fair Value
Non-vested — beginning of period	3,855,320		$	2.37
Granted	1,668,490		$	3.55
Vested	(1,610,271	)	$	2.48
Forfeited	(480,184	)	$	3.06
Non-vested - end of period	3,433,355		$	2.80